Any ideas whether DARA wants to maintain a long-term ownership position in Surgivision or intends to monetize that investment at some point in the future, or intends to spoin off the Surgivision shares to DARA shareholders? The Surgivision IPO will presumably improve book value and the balance sheet overall for DARA but it won't directly impact revenues, earnings or cash.
Market Data 
Markets 
AI
